drugset / Trial / NCT00074841

Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India

NCT00074841

Phase 2/3 Completed 230 enrolled Pfizer
RandomizedTreatment

Summary

This primary objective of this study is to assess whether the combination of Azithromycin with chloroquine is non-inferior to the combination of sulfadoxine-pyrimethamine plus chloroquine, when used to treat uncomplicated cases of malaria due to Plasmodium falciparum in adults in India.

Timeline

Start
2003-09
Primary completion
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule
Subject Sulfadoxine-pyrimethamine Small molecule
Background Chloroquine Small molecule